In Vivo Laboratory Efficacy Data Standards Initiative
In vivo efficacy studies generate critical data for drug discovery, but the absence of agreed standards leads to fragmented, inconsistent, and difficult-to-reuse data sets. Current approaches rely on bespoke formats across pharma, CROs, and technology providers, making integration, regulatory submission, and AI-driven analysis inefficient and error-prone. While CDISC SEND provides a proven framework for toxicology […]